Harpoon Therapeutics, Inc
4000 Shoreline Court, Suite 250
South San Francisco
About Harpoon Therapeutics, Inc
Harpoon Therapeutics is an immuno-oncology company using a proprietary technology platform focused on T cell engagement to discover and develop novel biologics for the treatment of cancer and other diseases. The company is developing a broad portfolio of drug candidates, and plans to develop its own oncology products in the U.S., as well as selectively partner other products to access global markets.
CEO: Gerald McMahon, Ph.D.
Currently, there are no jobs for this employer on BioSpace.
Browse jobs with BioSpace Featured Employers here.